Control of Soybean Aphids with Super Low-Dose Spraying: Efficacy and Labor Savings

The soybean aphid (Aphis glycines Mats.) is a major insect pest in soybean production areas, with annual occurrences causing serious damage to the soybean crops. The purpose of this experiment was to compare the control effect on soybean aphid and working efficacy of two methods of spraying with Dimethoate, namely, super-low volume spraying and conventional volume spraying, carried on the back with a manual compression operation. The results obtained are as follows.Originating text in Chinese.Citation: Li, Yong, Lin, Peili, Liu, Yanping. (1989). Control of Soybean Aphids with Super Low-Dose Spraying: Efficacy and Labor Savings. Agricultural Sciences [in Heilongjiang Province], 1, 34-35

Two-particle azimuthal angle correlations and azimuthal charge balance function in relativistic heavy ion collisions

The two-particle azimuthal angle correlation (TPAC) and azimuthal charge balance function (ACBF) are used to study the anisotropic expansion in relativistic heavy ion collisions. It is demonstrated by the relativistic quantum molecular dynamics (RQMD) model and a multi-phase transport (AMPT) model that the small-angle correlation in TPAC indeed presents anisotropic expansion, and the large-angle (or back-to-back) correlation is mainly due to global momentum conservations. The AMPT model reproduces the observed TPAC, but the RQMD model fails to reproduce the strong correlations in both small and large azimuthal angles. The width of ACBF from RQMD and AMPT models decreases from peripheral to central collisions, consistent with experimental data, but in contrast to the expectation from thermal model calculations. The ACBF is insensitive to anisotropic expansion. It is a probe for the mechanism of hadronization, similar to the charge balance function in rapidity

Long-term yogurt consumption and risk of incident hypertension in adults

The Nurses' Health Study and Health Professionals Follow-up Study cohorts are supported by grants UM1 CA186107, UM1 CA176726, and UM1 CA167552 from the National Institutes of Health. The current analyses were supported by small grants from the National Dairy Council, the General Mills Bell Institute for Health and Nutrition, and the Boston Nutrition and Obesity Research Center. The Boston Nutrition Obesity Research Center is administratively based at Boston Medical Center and is funded by the National Institutes of Health (NIH/NIDDK) grant P30DK046200. (UM1 CA186107 - National Institutes of Health; UM1 CA176726 - National Institutes of Health; UM1 CA167552 - National Institutes of Health; small grants from the National Dairy Council; General Mills Bell Institute for Health and Nutrition; Boston Nutrition and Obesity Research Center; P30DK046200 - National Institutes of Health (NIH/NIDDK))Accepted manuscrip

Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects

BACKGROUND: The safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine (Sub/MF59™; FLUAD(®), Novartis Vaccines) was evaluated among elderly Chinese subjects (≥ 60 years of age). After a preliminary Phase I, open-label study (n = 25) to assess safety 1–14 days post-vaccination, a comparative observer-blind, randomised, controlled clinical trial (n = 600) was performed to assess safety and immunogenicity versus a non-adjuvanted subunit influenza vaccine (Subunit; Agrippal(®), Novartis Vaccines). Subjects were randomised (2:1) to receive Sub/MF59™ or Subunit. RESULTS: Both vaccines were well tolerated, with no vaccine-related serious adverse events reported during the Phase I trial. During the observer-blind study, local and systemic reactions were generally similar for both vaccines 1–22 days post-vaccination; however, injection-site induration was more frequent among the Subunit group (P < 0.05), and mild pain at the injection site and fever were more frequent among Sub/MF59™ recipients (P ≤ 0.005). Both vaccines induced a significant (P < 0.001) increase in geometric mean titres (GMTs) for the three strains tested, versus baseline; GMTs against A/H1N1, A/H3N2 and B were significantly higher in the Sub/MF59™ group (P = 0.034, P < 0.001 and P = 0.005, respectively). GMT ratios against A/H1N1, A/H3N2 and B were also significantly higher in the Sub/MF59™ group (P = 0.038, P < 0.001 and P = 0.006, respectively). Similarly, the percentage of subjects achieving seroprotection or seroconversion on Day 22 was greater for Sub/MF59™ recipients, reaching significance for A/H3N2 (P < 0.001). CONCLUSION: MF59™-adjuvanted subunit influenza vaccine is well tolerated by elderly Chinese subjects and induces a higher level of immunogenicity than a non-adjuvanted subunit influenza vaccine in this population that is at high risk of influenza-related complications. CLINICAL TRIAL REGISTRY: , NCT0031064